ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 312 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $800,352 | +14.1% | 22,444 | +29.7% | 0.01% | +16.7% |
| Q4 2022 | $701,688 | -53.3% | 17,300 | -61.9% | 0.01% | -53.8% |
| Q3 2022 | $1,502,000 | +311.5% | 45,422 | +338.4% | 0.01% | +225.0% |
| Q2 2022 | $365,000 | -54.9% | 10,361 | -41.1% | 0.00% | -42.9% |
| Q1 2022 | $809,000 | -35.1% | 17,600 | -6.3% | 0.01% | -36.4% |
| Q4 2021 | $1,246,000 | -20.8% | 18,787 | -1.1% | 0.01% | -35.3% |
| Q2 2021 | $1,573,000 | +524.2% | 18,996 | +399.8% | 0.02% | +466.7% |
| Q1 2021 | $252,000 | -78.6% | 3,801 | -75.2% | 0.00% | -81.2% |
| Q4 2020 | $1,176,000 | -12.6% | 15,321 | -51.0% | 0.02% | -38.5% |
| Q3 2020 | $1,346,000 | +20.8% | 31,251 | -61.8% | 0.03% | -56.7% |
| Q2 2018 | $1,114,000 | +129.7% | 81,900 | +21.8% | 0.06% | +66.7% |
| Q1 2018 | $485,000 | – | 67,257 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |